Dragana Milojković

机构：Imperial College Healthcare NHS Trust, Hammersmith Hospital, Centre for Inflammation Research, Imperial College London · ORCID：0000-0002-0593-8220

发表论文 305 篇 · 总被引 11002 次 · h-index 47

代表论文

• 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia (2025 · Leukemia · 被引 133)
• Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir (2023 · Clinical Infectious Diseases · 被引 62)
• Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance (2024 · Leukemia · 被引 26)
• Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score (2024 · Cardio-Oncology · 被引 15)
• Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia (2024 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 14)
• Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy (2024 · Leukemia · 被引 13)